人胎肝再生刺激因子治疗肝硬化的初步观察

An Observation on the Human Fetal Hepatic Stimulator Substance Treating Hepatocirrhosis

采用改良Ｌａｂｒｅｃｑｕｅ法，从人胎肝提取肝再生刺激因子（ＨＳＳ），并运用于治疗肝硬化病人（１５例），并设对照组（１５例）予以比较。结果：治疗组病例在自觉症状、体征及生化指标（ｒ－球蛋白、Ａ／Ｇ比值）等方面的改善明显优于对照组。并对ＨＳＳ的制备及应用作了介绍。

Human fetal liver was used to prepare hepatic stimulator substance(HSS)with modifiedLabrecque,s method to treat 15 cases of hepatocirrhosis. Other 15 cases were taken for con-trol.Results;The symptoms,signs and bilchemical indices(r-globulin,A/G)of HSS groupwere much more improved than those of the controls. The preparation and application of HSSwere introduced.